UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial

The Lancet (British edition), 2013-03, Vol.381 (9868), p.744-751

2013

Volltextzugriff (PDF)

Comparative efficacy and safety of alternative glucocorticoids regimens in patients with ANCA-associated vasculitis: a systematic review

BMJ open, 2022-02, Vol.12 (2), p.e050507-e050507

2022

Volltextzugriff (PDF)

Rituximab for treatment of severe renal disease in ANCA associated vasculitis

Journal of nephrology, 2016-04, Vol.29 (2), p.195-201

2016

Volltextzugriff (PDF)

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

The New England journal of medicine, 2010-07, Vol.363 (3), p.211-220

2010

Volltextzugriff (PDF)

Rituximab-associated hypogammaglobulinemia: Incidence, predictors and outcomes in patients with multi-system autoimmune disease

Journal of autoimmunity, 2015-02, Vol.57, p.60-65

2015

Volltextzugriff (PDF)

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial

Annals of the rheumatic diseases, 2015-06, Vol.74 (6), p.1178-1182

2015

Volltextzugriff (PDF)

Incidence and predictors of severe infections in ANCA-associated vasculitis: a population-based cohort study

Rheumatology (Oxford, England), 2021-06, Vol.60 (6), p.2745-2754

2021

Volltextzugriff (PDF)

Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis

The New England journal of medicine, 2024-03, Vol.390 (10), p.911-921

2024

Volltextzugriff (PDF)

Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial

Annals of internal medicine, 2009-05, Vol.150 (10), p.670

2009

Volltextzugriff (PDF)

The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease

BMC musculoskeletal disorders, 2014-05, Vol.15 (1), p.178-178, Article 178

2014

Volltextzugriff (PDF)

Anaemia, weight loss, and round shadows in the lungs

The Lancet (British edition), 2008-01, Vol.371 (9606), p.88-88

2008

Volltextzugriff (PDF)

Anti-B Cell Antibody Therapies for Inflammatory Rheumatic Diseases

Annual review of medicine, 2014-01, Vol.65 (1), p.263-278

2014

Volltextzugriff (PDF)

Immunoglobulin G replacement for the treatment of infective complications of rituximab-associated hypogammaglobulinemia in autoimmune disease: A case series

Journal of autoimmunity, 2015-02, Vol.57, p.24-29

2015

Volltextzugriff (PDF)

The characterisation and determinants of quality of life in ANCA associated vasculitis

Annals of the rheumatic diseases, 2014-01, Vol.73 (1), p.207-211

2014

Volltextzugriff (PDF)

Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis

Rheumatology (Oxford, England), 2012-04, Vol.51 (4), p.634-643

2012

Volltextzugriff (PDF)

Endothelin antagonism and sodium glucose Co-transporter 2 inhibition. A potential combination therapeutic strategy for COVID-19

Pulmonary pharmacology & therapeutics, 2021-08, Vol.69, p.102035-102035, Article 102035

2021

Volltextzugriff (PDF)

SP133IGA VASCULITIS (HENOCH-SCHÖNLEIN PURPURA): REFRACTORY AND RELAPSING DISEASE COURSE IN THE ADULT POPULATION

Nephrology, dialysis, transplantation, 2016-05, Vol.31 (suppl_1), p.i130-i130

2016

Volltextzugriff (PDF)

Progress in treatment of ANCA-associated vasculitis

Arthritis research & therapy, 2012-01, Vol.14 (2), p.210-210

2012

Volltextzugriff (PDF)

Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in antineutrophil cytoplasmic antibody–associated vasculitis

Journal of allergy and clinical immunology, 2017-05, Vol.139 (5), p.1684-1687.e10

2017

Volltextzugriff (PDF)

ANCA Associated Vasculitis Subtypes: Response [Letter]

Journal of inflammation research, 2022-01, Vol.15, p.5161-5162

2022

Volltextzugriff (PDF)

Treatment of Antineutrophil Cytoplasm Autoantibody-Associated Systemic Vasculitis: Initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group

Mayo Clinic proceedings, 1997-08, Vol.72 (8), p.737-747

1997

Volltextzugriff (PDF)

Determinants of outcome in ANCA-associated glomerulonephritis: A prospective clinico-histopathological analysis of 96 patients

Kidney international, 2002-11, Vol.62 (5), p.1732-1742

2002

Volltextzugriff (PDF)

Mycophenolate Mofetil in Anti-Neutrophil Cytoplasm Antibodies-Associated Systemic Vasculitis

Nephron. Clinical practice, 2006-01, Vol.102 (3-4), p.c100-c107

2006

Volltextzugriff (PDF)

Validation of the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by disease content experts

Rheumatic & musculoskeletal diseases open, 2017-01, Vol.3 (1), p.e000449-e000449

2017

Volltextzugriff (PDF)

Leucocyte subset-specific type 1 interferon signatures in SLE and other immune-mediated diseases

Rheumatic & musculoskeletal diseases open, 2016-01, Vol.2 (1), p.e000183-e000183

2016

Volltextzugriff (PDF)

1 – 25 von 31

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(31)

Sprache

Englisch
(31)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(27)
Science & Technology
(27)
Humans
(23)
Male
(11)
Middle Aged
(11)
Rheumatology
(11)
Rituximab
(11)
Vasculitis
(11)
Female
(10)
Immunosuppressive Agents - Therapeutic Use
(10)
Aged
(9)
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - Drug Therapy
(9)
General & Internal Medicine
(8)
Medicine, General & Internal
(8)
Treatment Outcome
(8)
Adult
(7)
Biological And Medical Sciences
(7)
Clinical Trials
(6)
Cyclophosphamide - Therapeutic Use
(6)
Drug Therapy, Combination
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial

Comparative efficacy and safety of alternative glucocorticoids regimens in patients with ANCA-associated vasculitis: a systematic review

Rituximab for treatment of severe renal disease in ANCA associated vasculitis

Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis

Rituximab-associated hypogammaglobulinemia: Incidence, predictors and outcomes in patients with multi-system autoimmune disease

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial

Incidence and predictors of severe infections in ANCA-associated vasculitis: a population-based cohort study

Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis

Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial

The effect of rituximab therapy on immunoglobulin levels in patients with multisystem autoimmune disease

Anaemia, weight loss, and round shadows in the lungs

Anti-B Cell Antibody Therapies for Inflammatory Rheumatic Diseases

Immunoglobulin G replacement for the treatment of infective complications of rituximab-associated hypogammaglobulinemia in autoimmune disease: A case series

The characterisation and determinants of quality of life in ANCA associated vasculitis

Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis

Endothelin antagonism and sodium glucose Co-transporter 2 inhibition. A potential combination therapeutic strategy for COVID-19

SP133IGA VASCULITIS (HENOCH-SCHÖNLEIN PURPURA): REFRACTORY AND RELAPSING DISEASE COURSE IN THE ADULT POPULATION

Progress in treatment of ANCA-associated vasculitis

Association of a TNFSF13B (BAFF) regulatory region single nucleotide polymorphism with response to rituximab in antineutrophil cytoplasmic antibody–associated vasculitis

ANCA Associated Vasculitis Subtypes: Response [Letter]

Treatment of Antineutrophil Cytoplasm Autoantibody-Associated Systemic Vasculitis: Initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group

Determinants of outcome in ANCA-associated glomerulonephritis: A prospective clinico-histopathological analysis of 96 patients

Mycophenolate Mofetil in Anti-Neutrophil Cytoplasm Antibodies-Associated Systemic Vasculitis

Validation of the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis by disease content experts

Leucocyte subset-specific type 1 interferon signatures in SLE and other immune-mediated diseases

Suchergebnisse filtern